A biomarker trial of BR-DIM (BioResponse 3,3’- Diindolylmethane) in patients with prostate cancer who undergo prostatectomy.
E. I. Heath
No relevant relationships to disclose
C. Hwang
No relevant relationships to disclose
M. L. Cher
No relevant relationships to disclose
L. K. Heilbrun
No relevant relationships to disclose
I. Powell
No relevant relationships to disclose
M. Menon
No relevant relationships to disclose
J. Li
No relevant relationships to disclose
M. Heath
No relevant relationships to disclose
S. Sethi
No relevant relationships to disclose
F. H. Sarkar
No relevant relationships to disclose